{"entity":{"type":"insider","cik":"0001604834","url":"/insider/0001604834","json_url":"/insider/0001604834.json","name":"Litton Mark James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":23,"first":"2014-11-24","last":"2026-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Litton Mark James","source":"filing","n_filings":23,"first_seen":"2014-11-24","last_seen":"2026-03-05"}],"transactions":[{"id":6168254,"accession":"0001604834-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001604834-26-000006","line_url":"/filing/0001604834-26-000006#line-2","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"LeonaBio, Inc.","issuer_ticker":"LONA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (PRESIDENT and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5156.0,"shares_display":"5,156","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":27687.72,"total_display":"27,687.72","total_whole":"27,688","shares_owned_after":57926.0,"shares_owned_after_display":"57,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":5872081,"accession":"0001604834-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001604834-26-000002","line_url":"/filing/0001604834-26-000002#line-2","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2586.0,"shares_display":"2,586","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":17791.68,"total_display":"17,791.68","total_whole":"17,792","shares_owned_after":40828.0,"shares_owned_after_display":"40,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-05","scope":"insider"},{"id":4683994,"accession":"0001415889-25-019069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-019069","line_url":"/filing/0001415889-25-019069#line-2","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25123.0,"shares_display":"25,123","price_per_share":0.2935,"price_display":"0.29","price_state":"stated","total_value":7373.6005,"total_display":"7,373.60","total_whole":"7,374","shares_owned_after":325802.0,"shares_owned_after_display":"325,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-02","scope":"insider"},{"id":4317789,"accession":"0001415889-25-000536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-000536","line_url":"/filing/0001415889-25-000536#line-2","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25107.0,"shares_display":"25,107","price_per_share":0.5619,"price_display":"0.56","price_state":"stated","total_value":14107.6233,"total_display":"14,107.62","total_whole":"14,108","shares_owned_after":242591.0,"shares_owned_after_display":"242,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-03","scope":"insider"},{"id":2190659,"accession":"0001415889-24-022983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-022983","line_url":"/filing/0001415889-24-022983#line-2","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5032.0,"shares_display":"5,032","price_per_share":0.566,"price_display":"0.57","price_state":"stated","total_value":2848.112,"total_display":"2,848.11","total_whole":"2,848","shares_owned_after":159365.0,"shares_owned_after_display":"159,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-05","filed_date":"2024-09-05","scope":"insider"},{"id":9287236,"accession":"0001415889-24-004153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-004153","line_url":"/filing/0001415889-24-004153#line-1","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4820.0,"shares_display":"4,820","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":14026.2,"total_display":"14,026.20","total_whole":"14,026","shares_owned_after":144397.0,"shares_owned_after_display":"144,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-02-16","scope":"insider"},{"id":2506059,"accession":"0001209191-24-001150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001150","line_url":"/filing/0001209191-24-001150#line-2","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4820.0,"shares_display":"4,820","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":14026.2,"total_display":"14,026.20","total_whole":"14,026","shares_owned_after":144397.0,"shares_owned_after_display":"144,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-08","scope":"insider"},{"id":6352667,"accession":"0001209191-22-039340","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-039340","line_url":"/filing/0001209191-22-039340#line-3","is_derivative":false,"issuer_cik":"0001604834","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001604834","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7960.0,"shares_display":"7,960","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":21412.4,"total_display":"21,412.40","total_whole":"21,412","shares_owned_after":128555.0,"shares_owned_after_display":"128,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-24","scope":"insider"},{"id":6862662,"accession":"0001209191-18-035863","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-035863","line_url":"/filing/0001209191-18-035863","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22727.0,"shares_display":"22,727","price_per_share":17.838325203502443,"price_display":"17.84","price_state":"stated","total_value":405411.6169,"total_display":"405,411.62","total_whole":"405,412","shares_owned_after":106663.0,"shares_owned_after_display":"106,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider","n_lines":2},{"id":4542923,"accession":"0001209191-17-060971","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-060971","line_url":"/filing/0001209191-17-060971#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16519.0,"shares_display":"16,519","price_per_share":10.8049,"price_display":"10.80","price_state":"stated","total_value":178486.1431,"total_display":"178,486.14","total_whole":"178,486","shares_owned_after":99932.0,"shares_owned_after_display":"99,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-15","scope":"insider"},{"id":4167331,"accession":"0001209191-17-057340","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057340","line_url":"/filing/0001209191-17-057340#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16520.0,"shares_display":"16,520","price_per_share":12.3307,"price_display":"12.33","price_state":"stated","total_value":203703.164,"total_display":"203,703.16","total_whole":"203,703","shares_owned_after":99932.0,"shares_owned_after_display":"99,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-18","scope":"insider"},{"id":4774687,"accession":"0001209191-17-004982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-004982","line_url":"/filing/0001209191-17-004982#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1498.0,"shares_display":"1,498","price_per_share":23.0966,"price_display":"23.10","price_state":"stated","total_value":34598.7068,"total_display":"34,598.71","total_whole":"34,599","shares_owned_after":99932.0,"shares_owned_after_display":"99,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-18","filed_date":"2017-01-20","scope":"insider"},{"id":4410625,"accession":"0001209191-17-003020","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-003020","line_url":"/filing/0001209191-17-003020#line-7","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":11500.0,"total_display":"11,500.00","total_whole":"11,500","shares_owned_after":99932.0,"shares_owned_after_display":"99,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-09","filed_date":"2017-01-09","scope":"insider"},{"id":4410621,"accession":"0001209191-17-003020","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-003020","line_url":"/filing/0001209191-17-003020#line-5","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6800.0,"shares_display":"6,800","price_per_share":23.0176,"price_display":"23.02","price_state":"stated","total_value":156519.68,"total_display":"156,519.68","total_whole":"156,520","shares_owned_after":99932.0,"shares_owned_after_display":"99,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-06","filed_date":"2017-01-09","scope":"insider"},{"id":4410615,"accession":"0001209191-17-003020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-003020","line_url":"/filing/0001209191-17-003020#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2216.0,"shares_display":"2,216","price_per_share":23.0019,"price_display":"23.00","price_state":"stated","total_value":50972.2104,"total_display":"50,972.21","total_whole":"50,972","shares_owned_after":99932.0,"shares_owned_after_display":"99,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-09","scope":"insider"},{"id":3045952,"accession":"0001209191-16-146390","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-146390","line_url":"/filing/0001209191-16-146390","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":27.499633333333332,"price_display":"27.50","price_state":"stated","total_value":164997.8,"total_display":"164,997.80","total_whole":"164,998","shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-17","filed_date":"2016-10-19","scope":"insider","n_lines":3},{"id":2666375,"accession":"0001209191-16-128063","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-128063","line_url":"/filing/0001209191-16-128063","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":28.943921666666668,"price_display":"28.94","price_state":"stated","total_value":173663.53,"total_display":"173,663.53","total_whole":"173,664","shares_owned_after":28100.0,"shares_owned_after_display":"28,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-15","scope":"insider","n_lines":6},{"id":2549963,"accession":"0001209191-16-124850","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-124850","line_url":"/filing/0001209191-16-124850#line-4","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19720.0,"shares_display":"19,720","price_per_share":30.049,"price_display":"30.05","price_state":"stated","total_value":592566.28,"total_display":"592,566.28","total_whole":"592,566","shares_owned_after":74567.0,"shares_owned_after_display":"74,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-01","scope":"insider"},{"id":2549954,"accession":"0001209191-16-124850","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-124850","line_url":"/filing/0001209191-16-124850#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5280.0,"shares_display":"5,280","price_per_share":30.0555,"price_display":"30.06","price_state":"stated","total_value":158693.04,"total_display":"158,693.04","total_whole":"158,693","shares_owned_after":74567.0,"shares_owned_after_display":"74,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-27","filed_date":"2016-06-01","scope":"insider"},{"id":2043531,"accession":"0001209191-16-090205","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-090205","line_url":"/filing/0001209191-16-090205","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":31.398056796,"price_display":"31.40","price_state":"stated","total_value":784951.4199,"total_display":"784,951.42","total_whole":"784,951","shares_owned_after":81427.0,"shares_owned_after_display":"81,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider","n_lines":2},{"id":8649154,"accession":"0001209191-15-074103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-074103","line_url":"/filing/0001209191-15-074103","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":32.26697253333333,"price_display":"32.27","price_state":"stated","total_value":242002.294,"total_display":"242,002.29","total_whole":"242,002","shares_owned_after":73479.0,"shares_owned_after_display":"73,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-05","scope":"insider","n_lines":2},{"id":8803111,"accession":"0001209191-15-059676","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-059676","line_url":"/filing/0001209191-15-059676#line-1","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":51.0959,"price_display":"51.10","price_state":"stated","total_value":383219.25,"total_display":"383,219.25","total_whole":"383,219","shares_owned_after":67655.0,"shares_owned_after_display":"67,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-06","scope":"insider"},{"id":8812304,"accession":"0001209191-15-051174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-051174","line_url":"/filing/0001209191-15-051174#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":44.2741,"price_display":"44.27","price_state":"stated","total_value":1106852.5,"total_display":"1,106,852.50","total_whole":"1,106,853","shares_owned_after":75155.0,"shares_owned_after_display":"75,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-04","filed_date":"2015-06-08","scope":"insider"},{"id":8644230,"accession":"0001209191-15-032441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-032441","line_url":"/filing/0001209191-15-032441#line-1","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":27.407,"price_display":"27.41","price_state":"stated","total_value":205552.5,"total_display":"205,552.50","total_whole":"205,553","shares_owned_after":74359.0,"shares_owned_after_display":"74,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-01","filed_date":"2015-04-03","scope":"insider"},{"id":8936895,"accession":"0001209191-15-007132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-007132","line_url":"/filing/0001209191-15-007132#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":28.5227,"price_display":"28.52","price_state":"stated","total_value":65602.21,"total_display":"65,602.21","total_whole":"65,602","shares_owned_after":81859.0,"shares_owned_after_display":"81,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-27","filed_date":"2015-01-28","scope":"insider"},{"id":8936892,"accession":"0001209191-15-007132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-007132","line_url":"/filing/0001209191-15-007132#line-1","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":28.0254,"price_display":"28.03","price_state":"stated","total_value":145732.08,"total_display":"145,732.08","total_whole":"145,732","shares_owned_after":84159.0,"shares_owned_after_display":"84,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-26","filed_date":"2015-01-28","scope":"insider"},{"id":6953427,"accession":"0001209191-14-070905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-070905","line_url":"/filing/0001209191-14-070905#line-1","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604834","owner_name":"Litton Mark James","owner_display_name":"Litton Mark James","owner_url":"/insider/0001604834","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":15.6337,"price_display":"15.63","price_state":"stated","total_value":469011.0,"total_display":"469,011.00","total_whole":"469,011","shares_owned_after":88484.0,"shares_owned_after_display":"88,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001620463","name":"LeonaBio, Inc.","url":"/issuer/0001620463","role":"Director, Officer (PRESIDENT and CEO)","n_filings":8,"first_seen":"2022-06-24","last_seen":"2026-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001423824","name":"ALDER BIOPHARMACEUTICALS INC","url":"/issuer/0001423824","role":"Officer (Chief Business Officer)","n_filings":15,"first_seen":"2014-11-24","last_seen":"2018-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604834","retrieved_at":"2026-08-23T16:31:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}